IM-12

CAS No. 1129669-05-1

IM-12( IM 12 | IM12 )

Catalog No. M10456 CAS No. 1129669-05-1

IM-12 is a novel potent GSK-3β inhibitor with IC50 of 53 nM, significantly increases the β-catenin level and activates canonical Wnt signalling.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 50 In Stock
5MG 46 In Stock
10MG 75 In Stock
25MG 149 In Stock
50MG 276 In Stock
100MG 458 In Stock
200MG Get Quote In Stock
500MG 1014 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    IM-12
  • Note
    Research use only, not for human use.
  • Brief Description
    IM-12 is a novel potent GSK-3β inhibitor with IC50 of 53 nM, significantly increases the β-catenin level and activates canonical Wnt signalling.
  • Description
    IM-12 is a novel potent GSK-3β inhibitor with IC50 of 53 nM, significantly increases the β-catenin level and activates canonical Wnt signalling; attenuates cell proliferation of ReNcell VM cells, induces nuclear accumulation of beta-catenin.
  • In Vitro
    IM-12 inhibits GSK-3β in ReNcell VM cells, with I50 of 3.8 μM. IM-12 (3 μM) enhances the β-catenin amount, with no further effect at lower or higher concentration. IM-12 (3 μM) also attenuates the proliferation of ReNCell VM cells. IM-12 increases TCF-activity of ReNcell VM.
  • In Vivo
    ——
  • Synonyms
    IM 12 | IM12
  • Pathway
    PI3K/Akt/mTOR signaling
  • Target
    GSK-3
  • Recptor
    GSK-3β
  • Research Area
    Other Indications
  • Indication
    ——

Chemical Information

  • CAS Number
    1129669-05-1
  • Formula Weight
    377.4115
  • Molecular Formula
    C22H20FN3O2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: ≥ 54.9 mg/mL
  • SMILES
    FC(C=C1)=CC=C1CCNC(C2=O)=C(C(N2C)=O)C(C3=C(C=CC=C3)N4)=C4C
  • Chemical Name
    1H-Pyrrole-2,5-dione, 3-[[2-(4-fluorophenyl)ethyl]amino]-1-methyl-4-(2-methyl-1H-indol-3-yl)-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Schm?le AC, et al. Bioorg Med Chem. 2010 Sep 15;18(18):6785-95.
molnova catalog
related products
  • CHIR-99021 trihydroc...

    A potent, specific GSK-3 inhibitor with IC50 of 5 nM and 10 nM for GSK3β and GSK3α, respectively.

  • Aloisine B

    Aloisine B (AloisineB) inhibited cyclin-dependent kinase and glycogen synthase kinase with IC50 values of 0.85 μM and 0.75 μM, respectively.

  • BRD0209

    BRD0209 is a highly selective, potent, reversible, ATP-competitive GSK3 inhibitor with IC50 of 19 nM/5 nM for GSK3α/GSK3β respectively.